This report contains market size and forecasts of Human Growth Hormone Drugs in global, including the following market information:
- Global Human Growth Hormone Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Human Growth Hormone Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Human Growth Hormone Drugs companies in 2021 (%)
The global Human Growth Hormone Drugs market was valued at 250 million in 2021 and is projected to reach US$ 328.6 million by 2028, at a CAGR of 4.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Norditropin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Growth Hormone Drugs include Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), GeneScience Pharmaceuticals Co., Ltd. (China), Merck KgaA (Germany), Novo Nordisk A/S (Denmark), Pfizer, Inc. (US) and Sandoz International GmbH (Germany), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Growth Hormone Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Growth Hormone Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Human Growth Hormone Drugs Market Segment Percentages, by Type, 2021 (%)
- Norditropin
- Genotropin
- Humatrope
- Saizen
- Omnitrope - the Somatropin Biosimilar
- Somatropin Biopartners
Global Human Growth Hormone Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Human Growth Hormone Drugs Market Segment Percentages, by Application, 2021 (%)
- Prader-Willi Syndrome
- Turner Syndrome
- Short Stature Homeobox Gene
- Small for Gestational Age
- Chronic Renal Insufficiency
- Short Bowel Syndrome
Global Human Growth Hormone Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Human Growth Hormone Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Human Growth Hormone Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Human Growth Hormone Drugs revenues share in global market, 2021 (%)
- Key companies Human Growth Hormone Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
- Key companies Human Growth Hormone Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Eli Lilly and Company (US)
- Ferring Holding SA (Switzerland)
- Genentech, Inc. (US)
- GeneScience Pharmaceuticals Co., Ltd. (China)
- Merck KgaA (Germany)
- Novo Nordisk A/S (Denmark)
- Pfizer, Inc. (US)
- Sandoz International GmbH (Germany)
